Design a new program or add to an existing program within the organization. Program design shall include, but is not limited to, the development of protocols and tools for: A. Laboratory testing as clinically indicated - full CBC and hemoglobin electrophoresis to detect sickle cell trait or hemoglobinopathy trait-with a focus on thalassemia trait . (Further genetic testing may be needed for some cases.) B. Notification of Results (both to the client and, if identified, a primary care provider.) C. Genetic counseling and education for each individual client in order to assure that well informed decisions are made regarding health and reproductive implications of positive results. D. Medical records documentation, consistent with accepted medical standards of care. E. Educational materials on sickle cell trait and hemoglobinopathy (including thalassemia) trait, its inheritance pattern, and potential health implications and reproductive implications/options. F. Client evaluation of program and response to receiving results and the changes if any that will come from the results and knowledge
